0000950170-23-031841.txt : 20230705
0000950170-23-031841.hdr.sgml : 20230705
20230705204346
ACCESSION NUMBER: 0000950170-23-031841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Le-Nguyen Quoc
CENTRAL INDEX KEY: 0001792062
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 231071719
MAIL ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
4
X0407
4
2023-06-30
0001785173
89bio, Inc.
ETNB
0001792062
Le-Nguyen Quoc
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
false
true
false
false
See Remarks
false
Common Stock
2023-06-30
4
A
false
8334
0.00
A
173305
D
Common Stock
2023-06-30
4
F
false
2882
18.95
D
170423
D
Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of corporate performance objectives.
These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
Chief Technical Operations Officer and Head of Quality
/s/ Ryan A. Murr, as attorney-in-fact for Quoc Le-Nguyen
2023-07-05